HUP9603327A2 - Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére - Google Patents

Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére

Info

Publication number
HUP9603327A2
HUP9603327A2 HU9603327A HUP9603327A HUP9603327A2 HU P9603327 A2 HUP9603327 A2 HU P9603327A2 HU 9603327 A HU9603327 A HU 9603327A HU P9603327 A HUP9603327 A HU P9603327A HU P9603327 A2 HUP9603327 A2 HU P9603327A2
Authority
HU
Hungary
Prior art keywords
living
peptidelike
organismus
applicating
compounds
Prior art date
Application number
HU9603327A
Other languages
English (en)
Inventor
Zoltán Dárdai
Original Assignee
Zoltán Dárdai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoltán Dárdai filed Critical Zoltán Dárdai
Priority to HU9603327A priority Critical patent/HU223205B1/hu
Publication of HU9603327D0 publication Critical patent/HU9603327D0/hu
Priority to CZ19991920A priority patent/CZ289788B6/cs
Priority to NZ336045A priority patent/NZ336045A/xx
Priority to EP97943081A priority patent/EP0942743B1/en
Priority to APAP/P/1999/001554A priority patent/AP1065A/en
Priority to JP52537298A priority patent/JP2001505222A/ja
Priority to AU44688/97A priority patent/AU744380B2/en
Priority to CN97180273A priority patent/CN1239436A/zh
Priority to EA199900438A priority patent/EA002023B1/ru
Priority to DE69710918T priority patent/DE69710918T2/de
Priority to PCT/HU1997/000049 priority patent/WO1998024470A1/en
Priority to IL12991597A priority patent/IL129915A0/xx
Priority to DK97943081T priority patent/DK0942743T3/da
Priority to CA002272604A priority patent/CA2272604A1/en
Priority to BR9714945-4A priority patent/BR9714945A/pt
Priority to TR1999/01232T priority patent/TR199901232T2/xx
Priority to AT97943081T priority patent/ATE213954T1/de
Priority to US09/319,282 priority patent/US6399566B1/en
Priority to SK687-99A priority patent/SK284306B6/sk
Priority to ES97943081T priority patent/ES2174291T3/es
Priority to KR10-1999-7004908A priority patent/KR100466757B1/ko
Publication of HUP9603327A2 publication Critical patent/HUP9603327A2/hu
Publication of HUP9603327A3 publication Critical patent/HUP9603327A3/hu
Priority to IS5052A priority patent/IS5052A/is
Priority to NO992668A priority patent/NO992668D0/no
Priority to OA9900140A priority patent/OA11180A/en
Publication of HU223205B1 publication Critical patent/HU223205B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya helyileg alkalmazható készítmény peptidszerűgyógyhatású anyagők élő szervezetbe vitelére, amely (i) peptidszerű gyógyhatású anyagőt, (ii) kapszaicint, hisztamint és/vagy kőrisbőgár kivőnatőt, és (iii) hámősítószert tartalmaz, a helyileg alkalmazható gyógyászati készítmények szőkásőshőrdőzóanyagaival és/vagy hígítószereivel összekeverve, adőtt esetbena bőrhöz tapadni képes hőrdőzóanyagra felvive. A találmány szerinti készítmény (i) kőmpőnense különösen előnyöseninzűlin lehet. ŕ
HU9603327A 1996-12-03 1996-12-03 Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére HU223205B1 (hu)

Priority Applications (24)

Application Number Priority Date Filing Date Title
HU9603327A HU223205B1 (hu) 1996-12-03 1996-12-03 Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
KR10-1999-7004908A KR100466757B1 (ko) 1996-12-03 1997-09-08 생체에 펩티드성 약물을 유입시키기 위한 국소 제제
DK97943081T DK0942743T3 (da) 1996-12-03 1997-09-08 Topisk præparat til indføring af peptid-farmaka i levende organismer
BR9714945-4A BR9714945A (pt) 1996-12-03 1997-09-08 Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
EP97943081A EP0942743B1 (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms
APAP/P/1999/001554A AP1065A (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms.
JP52537298A JP2001505222A (ja) 1996-12-03 1997-09-08 生物体にペプチド系医薬を導入するための局所用製剤
AU44688/97A AU744380B2 (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms
CN97180273A CN1239436A (zh) 1996-12-03 1997-09-08 用于将肽药物引入生物体的局部制剂
EA199900438A EA002023B1 (ru) 1996-12-03 1997-09-08 Фармацевтическая композиция местного применения для введения в живой организм, содержащая пептидное лекарственное средство
DE69710918T DE69710918T2 (de) 1996-12-03 1997-09-08 Topisches präparat zur abgabe eines peptidarzneimittels in lebewesen
PCT/HU1997/000049 WO1998024470A1 (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms
IL12991597A IL129915A0 (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms
CZ19991920A CZ289788B6 (cs) 1996-12-03 1997-09-08 Topický přípravek pro zavádění peptidických farmak do ľivých organismů
CA002272604A CA2272604A1 (en) 1996-12-03 1997-09-08 Topical preparation for introducing peptidaceous pharmacons in living organisms
NZ336045A NZ336045A (en) 1996-12-03 1997-09-08 Topical preparation containing a polypeptide, an epithelizing agent and capsaicine, histamine and/or cantharis extract
TR1999/01232T TR199901232T2 (xx) 1996-12-03 1997-09-08 Canl� organizmalara peptitli farmakonlar�n verilmesi i�in lokal terkip.
AT97943081T ATE213954T1 (de) 1996-12-03 1997-09-08 Topisches präparat zur abgabe eines peptidarzneimittels in lebewesen
US09/319,282 US6399566B1 (en) 1996-12-03 1997-09-08 Topical preparation for introducing insulin in living organisms
SK687-99A SK284306B6 (sk) 1996-12-03 1997-09-08 Topický prípravok na zavádzanie peptidických farmák do živých organizmov
ES97943081T ES2174291T3 (es) 1996-12-03 1997-09-08 Preparacion topica para introducir medicamentos peptidicos en organismos vivos.
IS5052A IS5052A (is) 1996-12-03 1999-05-18 Samsetning til að bera á húð til að innleiða peptíðtengd lyf í lifandi lífverur
NO992668A NO992668D0 (no) 1996-12-03 1999-06-02 Topisk preparat for innf°ring av farmas°ytisk aktive peptidforbindelser i levende organismer
OA9900140A OA11180A (en) 1996-12-03 1999-06-23 Topical preparation for introducing peptidaceous pharmacons in living organisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9603327A HU223205B1 (hu) 1996-12-03 1996-12-03 Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére

Publications (4)

Publication Number Publication Date
HU9603327D0 HU9603327D0 (en) 1997-01-28
HUP9603327A2 true HUP9603327A2 (hu) 1998-10-28
HUP9603327A3 HUP9603327A3 (en) 1998-11-30
HU223205B1 HU223205B1 (hu) 2004-03-29

Family

ID=89994502

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603327A HU223205B1 (hu) 1996-12-03 1996-12-03 Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére

Country Status (24)

Country Link
US (1) US6399566B1 (hu)
EP (1) EP0942743B1 (hu)
JP (1) JP2001505222A (hu)
KR (1) KR100466757B1 (hu)
CN (1) CN1239436A (hu)
AP (1) AP1065A (hu)
AT (1) ATE213954T1 (hu)
AU (1) AU744380B2 (hu)
BR (1) BR9714945A (hu)
CA (1) CA2272604A1 (hu)
CZ (1) CZ289788B6 (hu)
DE (1) DE69710918T2 (hu)
DK (1) DK0942743T3 (hu)
EA (1) EA002023B1 (hu)
ES (1) ES2174291T3 (hu)
HU (1) HU223205B1 (hu)
IL (1) IL129915A0 (hu)
IS (1) IS5052A (hu)
NO (1) NO992668D0 (hu)
NZ (1) NZ336045A (hu)
OA (1) OA11180A (hu)
SK (1) SK284306B6 (hu)
TR (1) TR199901232T2 (hu)
WO (1) WO1998024470A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225734B1 (en) * 1999-07-28 2007-07-30 Zoltan Dardai Multilayer plaster for introducing peptidaceous pharmacons in living organisms and process for producing thereof
EP1229939A1 (en) * 1999-07-30 2002-08-14 Maxim Pharmaceuticals, Inc. Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
WO2004069180A2 (en) 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
KR101457263B1 (ko) * 2012-02-03 2014-11-07 단국대학교 산학협력단 파스의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3009143A1 (de) 1980-03-10 1981-10-01 Hans Dr Bauersfeld Arzneimittelzubereitung und deren verwendung
JPS5879913A (ja) * 1981-11-09 1983-05-13 Taizo Ayukawa ヘアトニツク組成物
CA2079900A1 (en) * 1990-04-05 1991-10-06 Richard C. Potter Film-forming proteinaceous emulsion
CH687053A5 (fr) * 1993-10-05 1996-09-13 Crina Additifs pour l'alimentation animale et procédé pour leur préparation.
US5686100A (en) 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
AUPN089295A0 (en) * 1995-02-02 1995-03-02 International Diabetes Institute Treatment of diabetic neuropathy

Also Published As

Publication number Publication date
BR9714945A (pt) 2002-02-13
CN1239436A (zh) 1999-12-22
NO992668L (no) 1999-06-02
HUP9603327A3 (en) 1998-11-30
WO1998024470A1 (en) 1998-06-11
SK68799A3 (en) 2000-02-14
ES2174291T3 (es) 2002-11-01
US6399566B1 (en) 2002-06-04
DE69710918T2 (de) 2002-10-24
NZ336045A (en) 2000-10-27
HU9603327D0 (en) 1997-01-28
AP1065A (en) 2002-04-30
KR20000057371A (ko) 2000-09-15
EA199900438A1 (ru) 2000-02-28
CZ192099A3 (cs) 1999-09-15
SK284306B6 (sk) 2005-01-03
NO992668D0 (no) 1999-06-02
DE69710918D1 (de) 2002-04-11
CZ289788B6 (cs) 2002-04-17
CA2272604A1 (en) 1998-06-11
EP0942743B1 (en) 2002-03-06
JP2001505222A (ja) 2001-04-17
AU744380B2 (en) 2002-02-21
ATE213954T1 (de) 2002-03-15
OA11180A (en) 2003-05-12
TR199901232T2 (xx) 1999-08-23
DK0942743T3 (da) 2002-06-10
EP0942743A1 (en) 1999-09-22
EA002023B1 (ru) 2001-12-24
IL129915A0 (en) 2000-02-29
KR100466757B1 (ko) 2005-01-24
IS5052A (is) 1999-05-18
HU223205B1 (hu) 2004-03-29
AP9901554A0 (en) 1999-06-30
AU4468897A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
PL317105A1 (en) Compositions containing dna and p53 damaging agents
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
ZA803009B (en) Transdermal release system for pharmaceutical preparations
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
HUP0105058A2 (hu) Perifériás benzodiazepin receptorhoz kötődő anyag alkalmazása kutánstressz kezelésére
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
CA2215470A1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
BR9813514A (pt) Agente para tratamento de fibras queratìnicas
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
EP0387693A3 (de) Transdermales System mit gestufter Wirkstoffabgabe und Verwendung für die lokale oder systemische, kosmetische Wirkstoffverabreichung
HUP9603327A2 (hu) Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
EP0402933A3 (en) Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
EP0373195A4 (en) COMPOSITION FOR IN-VIVO OR IN-VITRO INCREASE IN MELANINE CONTENT OF THE MELANOCYTES AND THEIR USE IN-VITRO.
EP1180017B8 (en) Preparations with povidon iodine for wound treatment

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20040218

MM4A Lapse of definitive patent protection due to non-payment of fees